Basia Medical
Basia Medical develops AI-enabled medical devices for cervical cancer prevention, addressing two critical gaps in care: barriers to screening and loss to follow-up after abnormal results. Its Safi platform is a new cervical examination and sampling device designed to make screening more comfortable and accessible, while Wema is a digital health platform that automates patient follow-up. Both products are in development and not yet commercially available.
- Healthcare Technology
- Medical Devices
- Digital Health
- Artificial Intelligence
- Hardware
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Cervical cancer rates are rising among women aged 35–54 despite advances in HPV vaccination and screening. Many women are not screened regularly due to limited access to primary care, discomfort with traditional cervical examinations, and difficulties navigating the healthcare system, while others are lost to follow-up after abnormal results.
Solution
Basia Medical is developing two complementary products to address gaps in cervical cancer prevention. Safi is a new cervical examination and sampling device designed to make screening more comfortable, accessible, and practical for patients and healthcare providers. Wema is a digital health platform that automates patient follow-up after abnormal screening results, helping reduce loss to follow-up. Together, these tools integrate into existing clinical workflows to increase early detection rates and improve outcomes for women's health.
Target Audience
Primary users are healthcare providers and health systems involved in cervical cancer screening, including gynecologic oncologists, primary care clinicians, and public health programs seeking to improve screening participation and follow-up care.
Features
- Safi: a speculum-free cervical examination and sampling device designed to reduce patient discomfort and lower access barriers
- Wema: a digital health platform that automates follow-up care after abnormal screening results to reduce loss to follow-up
- AI-enabled medical device technology applied to cervical cancer screening and prevention
- Products designed to integrate into existing clinical workflows for practical adoption by healthcare providers
- Both products are in development and not yet available